These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 26310899)

  • 1. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
    Wang J; Yang M; Li Y; Han B
    Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
    Chen X; Lu P; Wang DD; Yang SJ; Wu Y; Shen HY; Zhong SL; Zhao JH; Tang JH
    Gene; 2016 Dec; 595(2):221-226. PubMed ID: 27746365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance.
    Rezaei Z; Sebzari A; Kordi-Tamandani DM; Dastjerdi K
    DNA Cell Biol; 2019 Feb; 38(2):184-192. PubMed ID: 30702337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype.
    Wang HJ; Guo YQ; Tan G; Dong L; Cheng L; Li KJ; Wang ZY; Luo HF
    J Cell Biochem; 2013 Oct; 114(10):2248-57. PubMed ID: 23606360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
    Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
    Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.
    Yao YS; Qiu WS; Yao RY; Zhang Q; Zhuang LK; Zhou F; Sun LB; Yue L
    Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
    Teoh SL; Das S
    Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
    Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
    J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-155 in drug resistance of breast cancer.
    Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
    Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary for molecular regulations of miRNAs in breast cancer.
    Yahya SM; Elsayed GH
    Clin Biochem; 2015 Apr; 48(6):388-96. PubMed ID: 25541018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
    Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
    Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-520h is crucial for DAPK2 regulation and breast cancer progression.
    Su CM; Wang MY; Hong CC; Chen HA; Su YH; Wu CH; Huang MT; Chang YW; Jiang SS; Sung SY; Chang JY; Chen LT; Chen PS; Su JL
    Oncogene; 2016 Mar; 35(9):1134-42. PubMed ID: 25982274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.